Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Chebib

Showing results (101-110 of 124) with videos related to

Pageof 13
Sort By:
The Journal of Biological Chemistry|February 8, 2019
Functional genomics of epilepsy-associated mutations in the GABA<sub>A</sub> receptor subunits reveal that one mutation impairs function and two are catastrophicNathan L Absalom, Philip K Ahring, Vivian W Liao, et al.
Molecular Pharmacology|August 4, 2011
2-Aminoethyl methylphosphonate, a potent and rapidly acting antagonist of GABA(A)-ρ1 receptorsAn Xie, Jun Yan, Lan Yue, et al.
Journal of Neurochemistry|February 9, 2007
The beta-amyloid protein of Alzheimer's disease binds to membrane lipids but does not bind to the alpha7 nicotinic acetylcholine receptorDavid H Small, Danuta Maksel, Megan L Kerr, et al.
ACS Chemical Neuroscience|July 11, 2012
Identifying the binding site of novel methyllycaconitine (MLA) analogs at α4β2 nicotinic acetylcholine receptorsGracia X J Quek, Diana Lin, Jill I Halliday, et al.
Annals of Clinical and Translational Neurology|July 12, 2023
Vinpocetine improved neuropsychiatric and epileptic outcomes in a patient with a GABRA1 loss-of-function variantCathrine E Gjerulfsen, Tomasz S Mieszczanek, Katrine M Johannesen, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 6, 2008
Novel, potent, and selective GABAC antagonists inhibit myopia development and facilitate learning and memoryMary Chebib, Tina Hinton, Katrina L Schmid, et al.
Neurobiology of Disease|May 5, 2026
A synonymous SLC2A1 variant causes familial epilepsy and paroxysmal exercise-induced dyskinesia by creating aberrant mosaic splicing patternsAdam T Higgins, Fiona Wang, William O Pickrell, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2012
α4βδ GABA(A) receptors are high-affinity targets for γ-hydroxybutyric acid (GHB)Nathan Absalom, Laura F Eghorn, Inge S Villumsen, et al.
Plos One|January 24, 2014
GABAA receptors containing ρ1 subunits contribute to in vivo effects of ethanol in miceYuri A Blednov, Jillian M Benavidez, Mendy Black, et al.
Neuropharmacology|January 18, 2015
Engineered α4β2 nicotinic acetylcholine receptors as models for measuring agonist binding and effect at the orthosteric low-affinity α4-α4 interfacePhilip K Ahring, Jeppe A Olsen, Elsebet Ø Nielsen, et al.
Pageof 13

Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
The Journal of Biological Chemistry|February 8, 2019
Functional genomics of epilepsy-associated mutations in the GABA<sub>A</sub> receptor subunits reveal that one mutation impairs function and two are catastrophicNathan L Absalom, Philip K Ahring, Vivian W Liao, et al.
Molecular Pharmacology|August 4, 2011
2-Aminoethyl methylphosphonate, a potent and rapidly acting antagonist of GABA(A)-ρ1 receptorsAn Xie, Jun Yan, Lan Yue, et al.
Journal of Neurochemistry|February 9, 2007
The beta-amyloid protein of Alzheimer's disease binds to membrane lipids but does not bind to the alpha7 nicotinic acetylcholine receptorDavid H Small, Danuta Maksel, Megan L Kerr, et al.
ACS Chemical Neuroscience|July 11, 2012
Identifying the binding site of novel methyllycaconitine (MLA) analogs at α4β2 nicotinic acetylcholine receptorsGracia X J Quek, Diana Lin, Jill I Halliday, et al.
Annals of Clinical and Translational Neurology|July 12, 2023
Vinpocetine improved neuropsychiatric and epileptic outcomes in a patient with a GABRA1 loss-of-function variantCathrine E Gjerulfsen, Tomasz S Mieszczanek, Katrine M Johannesen, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 6, 2008
Novel, potent, and selective GABAC antagonists inhibit myopia development and facilitate learning and memoryMary Chebib, Tina Hinton, Katrina L Schmid, et al.
Neurobiology of Disease|May 5, 2026
A synonymous SLC2A1 variant causes familial epilepsy and paroxysmal exercise-induced dyskinesia by creating aberrant mosaic splicing patternsAdam T Higgins, Fiona Wang, William O Pickrell, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2012
α4βδ GABA(A) receptors are high-affinity targets for γ-hydroxybutyric acid (GHB)Nathan Absalom, Laura F Eghorn, Inge S Villumsen, et al.
Plos One|January 24, 2014
GABAA receptors containing ρ1 subunits contribute to in vivo effects of ethanol in miceYuri A Blednov, Jillian M Benavidez, Mendy Black, et al.
Neuropharmacology|January 18, 2015
Engineered α4β2 nicotinic acetylcholine receptors as models for measuring agonist binding and effect at the orthosteric low-affinity α4-α4 interfacePhilip K Ahring, Jeppe A Olsen, Elsebet Ø Nielsen, et al.
Pageof 13